Company News
Mastering Your Company’s Narrative: Donna LaVoie to Present at the 2024 BIO International Convention
Whether in-licensing, out-licensing, or fundraising, shaping your company’s story is crucial. Don’t miss CEO Donna LaVoie’s presentation at the 2024 BIO International Convention where she will be teaming up with…
Read MoreGlobal Business Reports Interview with Donna LaVoie: Insights into Biotech Communication Strategies and the Current IPO Market
Donna LaVoie, CEO shares her thoughts in a Global Business Reports interview. She dives into the need to adapt biotechs’ communication strategies for different stages of funding, the current IPO…
Read MoreEmpowering Growth: LaVoieHealthScience Employees Participate in Emotional Intelligence Training
Thanks to the Workforce Training Grant from the Commonwealth Corporation, we have completed Emotional Intelligence training and have started presentation training led by Elise Simard, an employee development and corporate…
Read MoreLaVoieHealthScience Welcomes Katie Dodge as Senior Vice President and General Manager
Focus on Agency, Client Excellence, Growth, People and Best Practices BOSTON and NEW YORK – February 7, 2024 – LaVoieHealthScience (LHS), an integrated investor and public relations consulting agency focused…
Read MoreDonna LaVoie to moderate at BIO webinar on Jan 18, “Signals from JPM Week for 2024 Business Development Planning”
Donna LaVoie, President and CEO, will be moderating at the Biotechnology Innovation Organization on January 18th, between 2:00 and 3:00 pm ET. Learn about the dynamic shifts within the biotechnology…
Read MoreLaVoieHealthScience Joins Global Communications Network, IPREX
BOSTON & NEW YORK – October 19, 2023: LaVoieHealthScience (LHS), an integrated investor and public relations consulting agency focused on advancing health and science innovations, is now part of IPREX, the top independent…
Read More